Building in Bio
A new generation of multidisciplinary founders will build a new generation of bio companies, transforming not just health but food, agriculture, textiles, manufacturing—even software itself.
Featured
All Building in Bio News & Content
Adapting Biopharma to AI: A 2024 Update with Greg Meyers
Harnessing Water Dynamics for Drug Design with Michael Crackower and Jason Burch
Intersection of Biotech x High Tech with Vineeta Agarwala
AI in Pharmaceutical R&D with Kim Branson
Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
CRISPR by Design with Benjamin Oakes
Virtual Data Rooms: The Unsung Hero of Biotech Financing
Drag & Drop Genome Editing
AI Jobs to be Done in Life Sciences
Past, Present, and Future of AI with Vijay Pande
Gate Unveiling with Jordi Mata-Fink
Outclassed: The Battle for Therapeutic Market Share
is a general partner on the Bio + Health team at Andreessen Horowitz, focused on therapeutics, diagnostics, life sciences tools, and software.
Jay Rughani is a partner at Andreessen Horowitz, where he leads investments in health technology companies.
is a partner on the Bio + Health team focused on biotech. She leads business development for the a16z life sciences portfolio.
is a partner on the Talent Network Team focused on Executive Talent.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.